Cardiovascular-metabolic impact of adiponectin and aquaporin [Review]
暂无分享,去创建一个
[1] T. Funahashi,et al. Clinical importance of assessment of type 2 diabetes mellitus with visceral obesity. A Japanese perspective. , 2012, Current diabetes reviews.
[2] K. Clarke,et al. Modification of myocardial substrate use as a therapy for heart failure , 2006, Nature Clinical Practice Cardiovascular Medicine.
[3] G. Adler,et al. Mineralocorticoid Receptor Blockade Reverses Obesity-Related Changes in Expression of Adiponectin, Peroxisome Proliferator-Activated Receptor-&ggr;, and Proinflammatory Adipokines , 2008, Circulation.
[4] Y. Matsuzawa. Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease , 2006, Nature Clinical Practice Cardiovascular Medicine.
[5] Kok Weng Chan,et al. Testosterone Selectively Reduces the High Molecular Weight Form of Adiponectin by Inhibiting Its Secretion from Adipocytes* , 2005, Journal of Biological Chemistry.
[6] H. Lodish,et al. T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[7] A. Verkman,et al. Progressive Adipocyte Hypertrophy in Aquaporin-7-deficient Mice , 2005, Journal of Biological Chemistry.
[8] C. Mantzoros,et al. Adiponectin and breast cancer risk. , 2004, The Journal of clinical endocrinology and metabolism.
[9] J. Funder. Mineralocorticoid Receptors: Distribution and Activation , 2005, Heart Failure Reviews.
[10] S. Kihara,et al. Association of serum adiponectin levels with breast cancer risk. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[11] Philippe Froguel,et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects , 2003, Nature.
[12] J. Peters,et al. Expression of Putative Fatty Acid Transporter Genes Are Regulated by Peroxisome Proliferator-activated Receptor α and γ Activators in a Tissue- and Inducer-specific Manner* , 1998, The Journal of Biological Chemistry.
[13] Stefan Neubauer,et al. The failing heart--an engine out of fuel. , 2007, The New England journal of medicine.
[14] S. Kihara,et al. Association of Hypoadiponectinemia With Coronary Artery Disease in Men , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[15] M. Matsuda,et al. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. , 2003, Diabetes.
[16] W. Stremmel,et al. Isolation and partial characterization of a fatty acid binding protein in rat liver plasma membranes. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[17] Philippe Froguel,et al. Disruption of Adiponectin Causes Insulin Resistance and Neointimal Formation* , 2002, The Journal of Biological Chemistry.
[18] S. Kihara,et al. Adaptation to fasting by glycerol transport through aquaporin 7 in adipose tissue. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[19] Y. Nakano,et al. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. , 1996, Journal of biochemistry.
[20] C. Dina,et al. Genome-wide search for type 2 diabetes in Japanese affected sib-pairs confirms susceptibility genes on 3q, 15q, and 20q and identifies two new candidate Loci on 7p and 11p. , 2002, Diabetes.
[21] C. Bogardus,et al. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. , 2002, Diabetes.
[22] Takeshi Kimura,et al. Serum adiponectin level as an independent predictor of mortality in patients with congestive heart failure. , 2007, Circulation journal : official journal of the Japanese Circulation Society.
[23] M. Matsuda,et al. Coordinated regulation of fat-specific and liver-specific glycerol channels, aquaporin adipose and aquaporin 9. , 2002, Diabetes.
[24] Jan Frystyk,et al. Plasma Adiponectin, Body Mass Index, and Mortality in Patients With Chronic Heart Failure , 2005, Circulation.
[25] Jonathan Krakoff,et al. Adiponectin and development of type 2 diabetes in the Pima Indian population , 2002, The Lancet.
[26] M. Matsuda,et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 , 2002, Nature Medicine.
[27] R. Cardiff,et al. T-cadherin supports angiogenesis and adiponectin association with the vasculature in a mouse mammary tumor model. , 2008, Cancer research.
[28] H. Boeing,et al. Adiponectin and protection against type 2 diabetes mellitus , 2003, The Lancet.
[29] S. Kihara,et al. Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model. , 2007, Journal of hepatology.
[30] T. Tai,et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. , 2001, The Journal of clinical endocrinology and metabolism.
[31] Y. Matsuzawa,et al. Molecular cloning and expression of a novel human aquaporin from adipose tissue with glycerol permeability. , 1997, Biochemical and biophysical research communications.
[32] P. Grimaldi,et al. Expression of the CD36 homolog (FAT) in fibroblast cells: effects on fatty acid transport. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[33] Y. Matsuzawa,et al. Analysis of an expression profile of genes in the human adipose tissue. , 1997, Gene.
[34] K. Walsh,et al. Adiponectin Promotes Macrophage Polarization toward an Anti-inflammatory Phenotype* , 2009, The Journal of Biological Chemistry.
[35] David Couper,et al. Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study. , 2004, Diabetes.
[36] M. Lazar,et al. A futile metabolic cycle activated in adipocytes by antidiabetic agents , 2002, Nature Medicine.
[37] M. Matsuda,et al. Enhancement of the Aquaporin Adipose Gene Expression by a Peroxisome Proliferator-activated Receptor γ* , 2001, The Journal of Biological Chemistry.
[38] S. Kihara,et al. Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies. , 2007, The Journal of clinical investigation.
[39] H. Lodish,et al. Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein , 1994, Cell.
[40] H. Nakagama,et al. Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition , 2008, Gut.
[41] S. Kihara,et al. Adiponectin Protects Against Angiotensin II–Induced Cardiac Fibrosis Through Activation of PPAR-&agr; , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[42] S. Kihara,et al. Blockade of Angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation. , 2006, Kidney international.
[43] T. Ogihara,et al. Adiponectin and renal function, and implication as a risk of cardiovascular disease. , 2006, The American journal of cardiology.
[44] T Nakamura,et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[45] T. Ogihara,et al. Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease. , 2004, Journal of the American College of Cardiology.
[46] Joanne I. Yeh,et al. Structures of enterococcal glycerol kinase in the absence and presence of glycerol: correlation of conformation to substrate binding and a mechanism of activation by phosphorylation. , 2004, Biochemistry.
[47] T. Funahashi,et al. Metabolic syndrome: Clinical concept and molecular basis , 2007, Annals of medicine.
[48] M. Matsuda,et al. Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome. , 2002, Diabetes.
[49] T. Funahashi,et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). , 1996, Biochemical and biophysical research communications.
[50] S. Kihara,et al. Adiponectin Specifically Increased Tissue Inhibitor of Metalloproteinase-1 Through Interleukin-10 Expression in Human Macrophages , 2004, Circulation.
[51] C. Dina,et al. Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. , 2000, American journal of human genetics.
[52] S. Kihara,et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. , 2002, Journal of the American Society of Nephrology : JASN.
[53] S. Kihara,et al. Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice. , 2009, Cardiovascular research.
[54] B. Kahn,et al. Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus. , 1999, The New England journal of medicine.
[55] Alessandro Pontillo,et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. , 2003, JAMA.
[56] S. Kihara,et al. The heart requires glycerol as an energy substrate through aquaporin 7, a glycerol facilitator. , 2009, Cardiovascular research.
[57] S. Kihara,et al. Dynamic Changes of Adiponectin and S100A8 Levels by the Selective Peroxisome Proliferator–Activated Receptor-&ggr; Agonist Rivoglitazone , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[58] M. Gladka,et al. Aquaporin 7: the glycerol aquaeductus in the heart. , 2009, Cardiovascular research.
[59] T Nakamura,et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.
[60] J. Flier,et al. A Transgenic Model of Visceral Obesity and the Metabolic Syndrome , 2001, Science.
[61] S. Kihara,et al. Adiponectin-mediated modulation of hypertrophic signals in the heart , 2004, Nature Medicine.
[62] M. Matsuda,et al. Aquaporin Adipose, a Putative Glycerol Channel in Adipocytes* , 2000, The Journal of Biological Chemistry.
[63] Philipp E. Scherer,et al. A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes (*) , 1995, The Journal of Biological Chemistry.
[64] T. Funahashi,et al. Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure. , 2009, Journal of the American College of Cardiology.
[65] M. Igarashi,et al. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population: the Funagata study. , 2003, Diabetes care.
[66] S. Kihara,et al. Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin. , 2003, Gastroenterology.
[67] K. Shimamoto,et al. Blockade of the Renin-Angiotensin System Increases Adiponectin Concentrations in Patients With Essential Hypertension , 2003, Hypertension.
[68] J. Weber,et al. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[69] Cynthia J. Girman,et al. Plasma adiponectin levels and risk of myocardial infarction in men. , 2004, JAMA.
[70] T. Funahashi,et al. The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism. , 2011, Journal of atherosclerosis and thrombosis.
[71] S. Nielsen,et al. Vasopressin increases water permeability of kidney collecting duct by inducing translocation of aquaporin-CD water channels to plasma membrane. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[72] M. Matsuda,et al. Role of Adiponectin in Preventing Vascular Stenosis , 2002, The Journal of Biological Chemistry.
[73] A. Kimmel,et al. On the Control of Lipolysis in Adipocytes , 1999, Annals of the New York Academy of Sciences.
[74] M. Matsuda,et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. , 2002, Diabetes.
[75] F. Marumo,et al. Cloning and Functional Expression of a New Water Channel Abundantly Expressed in the Testis Permeable to Water, Glycerol, and Urea* , 1997, The Journal of Biological Chemistry.
[76] Morihiro Matsuda,et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. , 2004, The Journal of clinical investigation.
[77] S. Kihara,et al. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2–dependent mechanisms , 2005, Nature Medicine.
[78] J. Huss,et al. Nuclear receptor signaling and cardiac energetics. , 2004, Circulation research.
[79] S. Kihara,et al. Aquaporin 7 deficiency is associated with development of obesity through activation of adipose glycerol kinase. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[80] M. Matsuda,et al. Human aquaporin adipose (AQPap) gene. Genomic structure, promoter analysis and functional mutation. , 2002, European journal of biochemistry.
[81] P. Stenvinkel,et al. Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectin. , 2004, Kidney international.
[82] J. Huss,et al. Mitochondrial energy metabolism in heart failure: a question of balance. , 2005, The Journal of clinical investigation.
[83] M. Matsuda,et al. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. , 2001, Diabetes.
[84] T. Funahashi,et al. Decreased plasma adiponectin concentration in patients with essential hypertension. , 2003, American journal of hypertension.
[85] S. Kihara,et al. Reciprocal regulation of natriuretic peptide receptors by insulin in adipose cells. , 2010, Biochemical and biophysical research communications.
[86] T. Ogihara,et al. Hypoadiponectinemia Is an Independent Risk Factor for Hypertension , 2004, Hypertension.
[87] E. Hardeman,et al. Cardiac aquaporin expression in humans, rats, and mice. , 2006, American journal of physiology. Heart and circulatory physiology.
[88] M. Matsuda,et al. Genomic Structure and Insulin-mediated Repression of the Aquaporin Adipose (AQPap), Adipose-specific Glycerol Channel* , 2001, The Journal of Biological Chemistry.
[89] B. Spiegelman,et al. AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity (*) , 1996, The Journal of Biological Chemistry.
[90] L. Bernstein,et al. Effects of TNF-alpha neutralization on adipocytokines and skeletal muscle adiposity in the metabolic syndrome. , 2007, American journal of physiology. Endocrinology and metabolism.
[91] Kathryn N North,et al. Myocardial water handling and the role of aquaporins. , 2006, Biochimica et biophysica acta.
[92] D. Tanné,et al. Effects of Peroxisome Proliferator-Activated Receptor Ligands, Bezafibrate and Fenofibrate, on Adiponectin Level , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[93] T. Funahashi,et al. Aquaporins and glycerol metabolism. , 2006, Biochimica et biophysica acta.
[94] G. Calamita,et al. Insulin- and leptin-mediated control of aquaglyceroporins in human adipocytes and hepatocytes is mediated via the PI3K/Akt/mTOR signaling cascade. , 2011, The Journal of clinical endocrinology and metabolism.
[95] P. Ruiz-Lozano,et al. T-cadherin is critical for adiponectin-mediated cardioprotection in mice. , 2010, The Journal of clinical investigation.